Denis Naughten (Roscommon-Galway, Independent)
Link to this: Individually | In context | Oireachtas source

68. To ask the Minister for Health the role of genomic medicine in Ireland; and his plans for a national genomics strategy; and if he will make a statement on the matter. [25567/22]

Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Genomics has transformed our understanding of disease and our ability to deliver care in a way that is more specific and personal to each individual patient. By establishing the sequence of an individual’s genetic material, it is possible to identify sequences or mutations, which are specific to that person. Not only can these sequences identify the cause or stage of a disease, they can identify the risk of future disease and also help predict the likely benefits or side effects of a particular medication. Genomics has the potential to reshape clinical practice and to fundamentally change the way we prevent, diagnose, treat and monitor illness, providing the opportunity to have more precise and tailored treatments for patients.

Ireland is well placed to utilise genomic data. Currently, there are a number of relevant genomic initiatives being developed in both the clinical and research arenas, and by public and private enterprise. These initiatives need to be co-ordinated within a broader strategic approach to the use of genomic medicine in Ireland. It is for this reason that a National Genetics and Genomics Strategy needs to be developed.

The Department of Health is currently working with the HSE on the Steering Group tasked with the delivery a National Genetics and Genomic Strategy. The Strategy will help shape the future of genetics and genomics in Ireland. The Minister looks forward to introducing the Strategy once it is developed.